Public and patient interest in psychedelic-assisted psychotherapy is increasing, but people seeking access to psychedelic trials may be more clinically heterogeneous than the populations these trials can enrol. We conducted a cross-sectional descriptive analysis of previously unreported aggregate telephone-screening da...
Antonio Inserra, Luca Persico, Arianna Rosati et al.· Behavioral Science· 0 citations
Comorbid major depressive disorder (MDD) and substance use disorder (SUD) occur frequently and are challenging to manage. The negative impact of these co-occurring conditions on patient quality of life, functional ability, and mortality necessitates timely diagnosis and a multifaceted treatment approach. However, there...
Fabrizio Schifano, G. Martinotti, M. Wojnar et al.· Frontiers in Psychiatry· 0 citations
BACKGROUND
Depression is increasingly conceptualized as a biologically heterogeneous condition, with immune-inflammatory and metabolic dysregulation implicated in specific symptom dimensions rather than overall depressive severity. However, it remains unclear whether different combinations of inflammatory and metabolic...
M. Di Nicola, M. Pepe, A. Aguglia et al.· Psychoneuroendocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.